Ramesh Srinivasan
Executive Vice President and Chief Strategy Officer · McKesson
Executive Vice President and Chief Strategy Officer of McKesson since August 2026, leading enterprise and portfolio strategy. He joined McKesson in 2013 from McKinsey & Company and held senior roles in strategy, pricing and manufacturer relations. He holds a PhD in chemical engineering from Caltech. McKesson ranked No. 8 on the 2026 Fortune 500.
Last reviewed: Oct 1, 2026
Ramesh Srinivasan
Executive Vice President and Chief Strategy Officer McKesson
Last Reviewed: October 1, 2026
Executive Summary
Ramesh Srinivasan became McKesson’s Executive Vice President and Chief Strategy Officer on 1 August 2026, succeeding the retiring Thomas Rodgers. A member of the Executive Operating Team, he leads enterprise and portfolio strategy, including strategic investment priorities and portfolio decisions. He has been at McKesson since 2013, most recently running strategy and transformation for its North American pharmaceutical, oncology and multispecialty businesses, and was previously a healthcare consultant at McKinsey & Company. McKesson ranked No. 8 on the 2026 Fortune 500.
Career Highlights
- Executive Vice President and Chief Strategy Officer of McKesson since 1 August 2026.
- Senior Vice President and Chief Strategy and Transformation Officer, North American Pharmaceutical Services.
- Senior Vice President, Strategic Pricing and Manufacturer Relations.
- Associate Principal at McKinsey & Company before joining McKesson in 2013.
Professional Journey
Srinivasan earned a bachelor’s degree in chemical engineering at the University of Mumbai and a Master of Science and PhD in chemical engineering at the California Institute of Technology. At McKinsey & Company he rose to Associate Principal, advising biopharmaceutical manufacturers, wholesalers, specialty distributors, health systems and physician practice organisations.
He joined McKesson in 2013 and held senior roles in strategy, pricing, manufacturer relations and business transformation. As Senior Vice President of Strategic Pricing and Manufacturer Relations he oversaw manufacturer partnerships and pricing strategy, including the company’s approach to drug-pricing policy and cell and gene therapies. He then led strategy and transformation across McKesson’s pharmaceutical distribution, oncology and multispecialty businesses as Chief Strategy and Transformation Officer for North American Pharmaceutical Services.
In August 2026 he became Executive Vice President and Chief Strategy Officer. He serves on the boards of PRISM Vision Group and the Healthcare Distribution Alliance Research Foundation.
Education
California Institute of Technology
Doctor of Philosophy, Chemical Engineering
California Institute of Technology
Master of Science, Chemical Engineering
University of Mumbai
Bachelor’s degree, Chemical Engineering
